Oct4 differentially regulates chromatin opening and enhancer transcription in pluripotent stem cells

2022 | journal article; research paper. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Oct4 differentially regulates chromatin opening and enhancer transcription in pluripotent stem cells​
Xiong, L.; Tolen, E. A.; Choi, J.; Velychko, S.; Caizzi, L.; Velychko, T. & Adachi, K. et al.​ (2022) 
eLife11 art. e71533​.​ DOI: https://doi.org/10.7554/eLife.71533 

Documents & Media

elife-71533-v1.pdf12.53 MBAdobe PDF

License

Published Version

Attribution 4.0 CC BY 4.0

Details

Authors
Xiong, Le; Tolen, Erik A.; Choi, Jinmi; Velychko, Sergiy; Caizzi, Livia; Velychko, Taras; Adachi, Kenjiro; MacCarthy, Caitlin M.; Lidschreiber, Michael; Cramer, Patrick ; Schöler, Hans R.
Abstract
The transcription factor Oct4 is essential for the maintenance and induction of stem cell pluripotency, but its functional roles are not fully understood. Here, we investigate the functions of Oct4 by depleting and subsequently recovering it in mouse embryonic stem cells (ESCs) and conducting a time-resolved multiomics analysis. Oct4 depletion leads to an immediate loss of its binding to enhancers, accompanied by a decrease in mRNA synthesis from its target genes that are part of the transcriptional network that maintains pluripotency. Gradual decrease of Oct4 binding to enhancers does not immediately change the chromatin accessibility but reduces transcription of enhancers. Conversely, partial recovery of Oct4 expression results in a rapid increase in chromatin accessibility, whereas enhancer transcription does not fully recover. These results indicate different concentration-dependent activities of Oct4. Whereas normal ESC levels of Oct4 are required for transcription of pluripotency enhancers, low levels of Oct4 are sufficient to retain chromatin accessibility, likely together with other factors such as Sox2.
Issue Date
2022
Journal
eLife 
Project
EXC 2067: Multiscale Bioimaging 
Working Group
RG Cramer 
eISSN
2050-084X
Language
English
Sponsor
Deutsche Forschungsgemeinschaft
Deutsche Forschungsgemeinschaft
Deutsche Forschungsgemeinschaft
European Research Council
Max Planck Institute for Multidisciplinary Sciences
European Research Council
Max Planck Society
Max Planck Institute for Molecular Biomedicine

Reference

Citations


Social Media